Company profile
Emmes' Rare Disease and Pediatric Center
Emmes' Rare Disease and Pediatric Center: dedicated to global clinical development for rare diseases
- Industry
- Biotechnology Research
- Employees
- 23
- Headquarters
- Milton Keynes
- Founded
- 2002
- Office locations
- 7
Emmes' Rare Disease and Pediatric Center company summary
Emmes' Rare Disease and Pediatric Center is a company in the Biotechnology Research industry, headquartered in Milton Keynes, founded in 2002. On LinkedIn the company has around 23 employees. The company lists 7 office locations. Its listed specialties include Orphan Drugs, Rare Diseases, Rare Drugs, Orphan Development, Rare Development.
What technology does Emmes' Rare Disease and Pediatric Center use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Emmes' Rare Disease and Pediatric Center
Orphan Reach was a leading Contract Research Organization (CRO) designed to navigate the complexity of trials in orphan indications. As of the 11th May 2021, Orphan Reach were acquired by Emmes, a global, full-service CRO dedicated to supporting the advancement of public health and biopharmaceutical innovation. Since the acquisition, Orphan Reach has become part of Emmes - functioning as part of Emmes' Rare Disease and Pediatric Center. We are here to accelerate the clinical development of orphan drugs and facilitate patient access to urgently needed new treatments for rare conditions. For our customers – innovative biotech companies – we provide global clinical development services with particular attention to patient recruitment and retention. Our infrastructure allows access to patients with rare diseases in more than 100 countries world-wide. Centrally based Project Management teams in Europe, USA and Asia co-ordinate our task force in each of the local territories and contribute their orphan expertise to accelerate access to new drugs in a wide range of therapeutic areas. Combining Emmes’ strategic drug development and advanced statistical capabilities with the exceptional patient- centred global operational experience of Orphan Reach has further extended our leadership in rare and orphan disease research and will ultimately lead to new treatment options for patients.
Specialties
Where is Emmes' Rare Disease and Pediatric Center located?
Emmes' Rare Disease and Pediatric Center lists 7 office locations.
Compare companies similar to Emmes' Rare Disease and Pediatric Center
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Emmes' Rare Disease and Pediatric Center orphan-reach.com | Biotechnology Research | 23 | 2002 | Milton Keynes |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Emmes' Rare Disease and Pediatric Center
What does Emmes' Rare Disease and Pediatric Center do?
Orphan Reach was a leading Contract Research Organization (CRO) designed to navigate the complexity of trials in orphan indications. As of the 11th May 2021, Orphan Reach were acquired by Emmes, a global, full-service CRO dedicated to supporting the advancement of public health and biopharmaceutical innovation. Since the acquisition, Orphan Reach has become part of Emmes - functioning as part of Emmes' Rare Disease and Pediatric Center. We are here to accelerate the clinical development of orphan drugs and facilitate patient access to urgently needed new treatments for rare conditions. For our customers – innovative biotech companies – we provide global clinical development services with particular attention to patient recruitment and retention. Our infrastructure allows access to patients with rare diseases in more than 100 countries world-wide. Centrally based Project Management teams in Europe, USA and Asia co-ordinate our task force in each of the local territories and contribute their orphan expertise to accelerate access to new drugs in a wide range of therapeutic areas. Combining Emmes’ strategic drug development and advanced statistical capabilities with the exceptional patient- centred global operational experience of Orphan Reach has further extended our leadership in rare and orphan disease research and will ultimately lead to new treatment options for patients.
How many employees does Emmes' Rare Disease and Pediatric Center have?
Emmes' Rare Disease and Pediatric Center has around 23 employees on LinkedIn.
Where is Emmes' Rare Disease and Pediatric Center headquartered?
Emmes' Rare Disease and Pediatric Center is headquartered in Milton Keynes.
Where does Emmes' Rare Disease and Pediatric Center have offices?
Emmes' Rare Disease and Pediatric Center lists 7 office locations, including Milton Keynes, MK6 3AP, GB; Ahmedabad, Gujarat, IN; Berlin, 10341, DE; Cork, Cork T23 AT2P, IE; Lewes, Delaware, US.
When was Emmes' Rare Disease and Pediatric Center founded?
Emmes' Rare Disease and Pediatric Center was founded in 2002.
Build a lead list from companies like Emmes' Rare Disease and Pediatric Center
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.